Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization
US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on...
Cancer
AstraZeneca’s Imfinzi Gets Positive Opinion for Bladder Cancer Perioperative Treatment
UK-based pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) announced that the European Medicines Agency’s (EMA) Committee...
EMA Recommends Tevimbra for Nasopharyngeal Cancer First-line Treatment
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended...
CARsgen’s Satricabtagene Autoleucel Granted Priority Review by China’s CDE
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced that the Center for Drug Evaluation...
EpimAb Biotherapeutics and Juri Biosciences Ink Global Licensing Deal for KLK2-CD3 T-Cell Engager
Shanghai-based biotech EpimAb Biotherapeutics announced a global licensing agreement with US-headquartered Juri Biosciences, Inc., a...
Phanes Therapeutics Doses First Patient in CD73 Antibody Clinical Study
Sino-US biotech Phanes Therapeutics Inc. announced the first patient dosing in a clinical study for...
Drug Farm and Amoytop Biotech Collaborate on DF-006 for HBV and HCC
Sino-US biotech Drug Farm announced the signing of an option agreement with Xiamen-based Amoytop Biotech...
Kexing Pharma’s GB18 Receives NMPA Approval for Cancer Cachexia Trial
China-based Kexing Pharmaceutical (SHA: 688136) announced that it has received approval from the National Medical...
Hengrui Pharmaceuticals Gains NMPA Approval for SHR-4712 Clinical Trial
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received approval from the...
Fosun Pharma’s HLX22 Granted Orphan Drug Designation by EU Commission
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced that it has...
Kanghong Pharma Wins NMPA Approval for KH617 in Glioblastoma Trial
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773) announced that it has received clinical...
Jemincare’s Irinotecan Liposome Injection Gains NMPA Approval for Pancreatic Cancer
China-based Jiangxi Jemincare Group announced that it has received marketing approval from the National Medical...
GSK’s Blenrep Recommended for EU Approval in Multiple Myeloma
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that its Blenrep (belantamab mafodotin) has been...
Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Breakthrough Therapy Designation for HCC
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that it has received Breakthrough Therapy...
Medilink Therapeutics Collaborates with Wuhan Union Hospital on Clinical Trials
Suzhou-based Medilink Therapeutics announced a clinical study collaboration agreement with Union Hospital, Tongji Medical College,...
Roche’s Itovebi Recommended for EU Approval in PIK3CA-Mutated Breast Cancer
Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced that its Itovebi (inavolisib) has been...
CARsgen’s Satri-Cel Shows Significant Efficacy in Gastric Cancer Study
China-based CARsgen Therapeutics Holdings Limited (HKG: 2171) announced that it has published an abstract of...
Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening
China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with...
Servier Acquires BioNova’s BN104 for Acute Leukemia Treatment
French pharmaceutical firm Servier announced a definitive agreement to acquire BN104 from BioNova Pharmaceuticals (Shanghai)...
Kexing Biopharm’s GB18 Receives FDA Approval for Tumor Cachexia Clinical Trial
China-based Kexing Biopharm Co., Ltd. (SHA: 688136) announced receiving clinical trial approval from the US...